Sign in

CIK 0001041024

  • Non-accelerated filer
  • Smaller reporting company

ROCKWELL MEDICAL, INC.

Sign in to watch
Ticker
RMTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
383317208
Phone
+1 800-449-3353
Business address
30142 WIXOM ROAD, WIXOM, MI, 48393
Former names
ROCKWELL MEDICAL TECHNOLOGIES INC
  1. 4 Grant or award Director acquired 50,000 shares (grant or award)
  2. 4 Grant or award Director acquired 50,000 shares (grant or award)
  3. 4 Grant or award SVP, Chief Commercial Officer acquired 85,000 shares (grant or award)
  4. 4 Grant or award SVP, FINANCE AND CFO acquired 97,500 shares (grant or award)
  5. 4 Grant or award EVP, CLO and Secretary acquired 97,500 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 220,000 shares (grant or award)
  7. 4 Open-market buy 10% owner bought 87,500 shares at an average $1.07 ($94,018)
  8. 4 Planned sale President and CEO sold 6,926 shares at $1.08 ($7,480)
  9. 4 Planned sale SVP, FINANCE AND CFO sold 886 shares at $1.10 ($975)
  10. 4 Planned sale SVP, Chief Commercial Officer sold 2,868 shares at $1.08 ($3,097)
  11. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 5,267 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP, FINANCE AND CFO gave up 2,444 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, CLO and Secretary gave up 6,803 shares (to pay taxes)
  14. 4 Shares withheld for taxes President and CEO gave up 13,434 shares (to pay taxes)
  15. 4 Planned sale SVP, Chief Commercial Officer sold 1,001 shares at $2.05 ($2,052)
  16. 4 Planned sale President and CEO sold 2,163 shares at $2.06 ($4,445)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Director sold 29,991 shares at an average $2.35 ($70,379)
  19. 4 Planned sale SVP, Chief Commercial Officer sold 1,001 shares at $3.69 ($3,689)
  20. 4 Planned sale President and CEO sold 2,163 shares at $3.69 ($7,971)

Page 3 of 24 · 470 filings